Suchergebnisse - "Akula, Sravani"

PubPharm (13)

1

Large-scale pathogenicity prediction analysis of cancer-associated kinase mutations reveals variability in sensitivity and specificity of computational methods

enthalten in: Cancer medicine | 2023

von Akula, S. | Mullaguri, S. | Melton, N. | +6

2

Applications of promiscuity of FDA-approved kinase inhibitors in drug repositioning and toxicity

enthalten in: Toxicology and applied pharmacology | 2023

von Korikani, M. | Fathima, N. | Nadiminti, G. | +2

3

Large‐scale pathogenicity prediction analysis of cancer‐associated kinase mutations reveals variability in sensitivity and specificity of computational methods

enthalten in: Cancer Medicine | 2023

von Akula, S. | Mullaguri, S. | Melton, N. | +6

4

Molecular docking analysis reveals differential binding affinities of multiple classes of selective inhibitors towards cancer-associated KRAS mutants

enthalten in: 3 Biotech | 2022

von Mullaguri, S. | Akula, S. | Sahoo, P. | +5

5

Molecular docking analysis reveals differential binding affinities of multiple classes of selective inhibitors towards cancer-associated KRAS mutants

enthalten in: 3 Biotech | 2022

von Mullaguri, S. | Akula, S. | Sahoo, P. | +5

6

Molecular docking analysis reveals differential binding affinities of multiple classes of selective inhibitors towards cancer-associated KRAS mutants

enthalten in: 3 Biotech | 2022

von Mullaguri, S. | Akula, S. | Sahoo, P. | +5

7

Molecular docking analysis reveals differential binding affinities of multiple classes of selective inhibitors towards cancer-associated KRAS mutants

enthalten in: 3 Biotech | 2022

von Mullaguri, S. | Akula, S. | Sahoo, P. | +5

8

Estimated sensitivity profiles of lung cancer specific uncommon BRAF mutants towards experimental and clinically approved kinase inhibitors

enthalten in: Toxicology and applied pharmacology | 2022

von Mullaguri, S. | Akula, S. | Ashireddygari, V. | +8

9

Elucidation of conformational diversity of druggable enzymes and classification of chemical modulators based on inhibitor-bound structures

enthalten in: Journal of biomolecular structure & dynamics | 2019

von Akula, S. | Vanamamalai, V. | Nair Ru, V. | +2

10

Consensus anticancer activity profiles derived from the meta-analysis of reference compounds for widely used cell lines

enthalten in: Future medicinal chemistry | 2019

von Chermala, D. | Akula, S. | Ravula, S. | +2